| UniProt ID | HM13_HUMAN | |
|---|---|---|
| UniProt AC | Q8TCT9 | |
| Protein Name | Minor histocompatibility antigen H13 | |
| Gene Name | HM13 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 377 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Membrane Multi-pass membrane protein Lumenal side . Isoform 4: Cell membrane Multi-pass membrane protein . |
|
| Protein Description | Catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein, resulting in the release of the fragment from the ER membrane into the cytoplasm. Required to generate lymphocyte cell surface (HLA-E) epitopes derived from MHC class I signal peptides. [PubMed: 11714810 May be necessary for the removal of the signal peptide that remains attached to the hepatitis C virus core protein after the initial proteolytic processing of the polyprotein] | |
| Protein Sequence | MDSALSDPHNGSAEAGGPTNSTTRPPSTPEGIALAYGSLLLMALLPIFFGALRSVRCARGKNASDMPETITSRDAARFPIIASCTLLGLYLFFKIFSQEYINLLLSMYFFVLGILALSHTISPFMNKFFPASFPNRQYQLLFTQGSGENKEEIINYEFDTKDLVCLGLSSIVGVWYLLRKHWIANNLFGLAFSLNGVELLHLNNVSTGCILLGGLFIYDVFWVFGTNVMVTVAKSFEAPIKLVFPQDLLEKGLEANNFAMLGLGDVVIPGIFIALLLRFDISLKKNTHTYFYTSFAAYIFGLGLTIFIMHIFKHAQPALLYLVPACIGFPVLVALAKGEVTEMFSYEESNPKDPAAVTESKEGTEASASKGLEKKEK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | N-linked_Glycosylation | SALSDPHNGSAEAGG CCCCCCCCCCCCCCC | 52.05 | 12077416 | |
| 10 | N-linked_Glycosylation | SALSDPHNGSAEAGG CCCCCCCCCCCCCCC | 52.05 | 12077416 | |
| 12 | Phosphorylation | LSDPHNGSAEAGGPT CCCCCCCCCCCCCCC | 28.40 | 20860994 | |
| 20 | N-linked_Glycosylation | AEAGGPTNSTTRPPS CCCCCCCCCCCCCCC | 40.26 | 12077416 | |
| 20 | N-linked_Glycosylation | AEAGGPTNSTTRPPS CCCCCCCCCCCCCCC | 40.26 | 12077416 | |
| 61 (in isoform 2) | Ubiquitination | - | 43.73 | 21890473 | |
| 61 | Malonylation | SVRCARGKNASDMPE HHHHHCCCCHHHCCC | 43.73 | 26320211 | |
| 61 | Ubiquitination | SVRCARGKNASDMPE HHHHHCCCCHHHCCC | 43.73 | 21906983 | |
| 61 (in isoform 5) | Ubiquitination | - | 43.73 | 21890473 | |
| 61 (in isoform 4) | Ubiquitination | - | 43.73 | 21890473 | |
| 61 (in isoform 1) | Ubiquitination | - | 43.73 | 21890473 | |
| 64 | Phosphorylation | CARGKNASDMPETIT HHCCCCHHHCCCCCC | 43.78 | 21712546 | |
| 66 | Sulfoxidation | RGKNASDMPETITSR CCCCHHHCCCCCCHH | 2.75 | 21406390 | |
| 69 | Phosphorylation | NASDMPETITSRDAA CHHHCCCCCCHHHHH | 24.55 | 27732954 | |
| 71 | Phosphorylation | SDMPETITSRDAARF HHCCCCCCHHHHHHC | 25.73 | 27732954 | |
| 72 | Phosphorylation | DMPETITSRDAARFP HCCCCCCHHHHHHCH | 25.06 | 27732954 | |
| 90 | Phosphorylation | SCTLLGLYLFFKIFS HHHHHHHHHHHHHHC | 10.32 | - | |
| 138 | Phosphorylation | ASFPNRQYQLLFTQG CCCCCCEEEEEEECC | 9.63 | - | |
| 150 (in isoform 1) | Ubiquitination | - | 53.04 | 21890473 | |
| 150 (in isoform 4) | Ubiquitination | - | 53.04 | 21890473 | |
| 150 (in isoform 2) | Ubiquitination | - | 53.04 | 21890473 | |
| 150 (in isoform 5) | Ubiquitination | - | 53.04 | 21890473 | |
| 150 | Ubiquitination | TQGSGENKEEIINYE ECCCCCCHHHEEEEE | 53.04 | 21906983 | |
| 156 | Phosphorylation | NKEEIINYEFDTKDL CHHHEEEEECCCCCC | 13.94 | - | |
| 199 (in isoform 5) | Ubiquitination | - | 3.20 | 21890473 | |
| 241 (in isoform 2) | Ubiquitination | - | 37.22 | 21890473 | |
| 241 | Ubiquitination | KSFEAPIKLVFPQDL HHCCCCEEEECCHHH | 37.22 | 20639865 | |
| 241 (in isoform 4) | Ubiquitination | - | 37.22 | 21890473 | |
| 241 (in isoform 1) | Ubiquitination | - | 37.22 | 21890473 | |
| 241 | Ubiquitination | KSFEAPIKLVFPQDL HHCCCCEEEECCHHH | 37.22 | 21890473 | |
| 242 (in isoform 5) | Ubiquitination | - | 5.06 | 21890473 | |
| 284 | Ubiquitination | LRFDISLKKNTHTYF HHCCEECCCCCCCCC | 36.87 | 21906983 | |
| 284 (in isoform 4) | Ubiquitination | - | 36.87 | 21890473 | |
| 284 (in isoform 2) | Ubiquitination | - | 36.87 | 21890473 | |
| 284 (in isoform 1) | Ubiquitination | - | 36.87 | 21890473 | |
| 310 (in isoform 5) | Ubiquitination | - | 19.95 | 21890473 | |
| 319 (in isoform 5) | Ubiquitination | - | 4.04 | 21890473 | |
| 328 (in isoform 5) | Ubiquitination | - | 22.23 | 21890473 | |
| 341 | Phosphorylation | ALAKGEVTEMFSYEE HHHCCCEEECEECCC | 19.89 | 20860994 | |
| 343 | Sulfoxidation | AKGEVTEMFSYEESN HCCCEEECEECCCCC | 1.65 | 28465586 | |
| 345 | Phosphorylation | GEVTEMFSYEESNPK CCEEECEECCCCCCC | 30.26 | 20860994 | |
| 346 | Phosphorylation | EVTEMFSYEESNPKD CEEECEECCCCCCCC | 16.67 | 27642862 | |
| 352 (in isoform 1) | Ubiquitination | - | 79.27 | 21890473 | |
| 352 | Acetylation | SYEESNPKDPAAVTE ECCCCCCCCCCCCCC | 79.27 | 26051181 | |
| 352 | Ubiquitination | SYEESNPKDPAAVTE ECCCCCCCCCCCCCC | 79.27 | 21906983 | |
| 356 (in isoform 2) | Phosphorylation | - | 17.72 | 24719451 | |
| 356 (in isoform 4) | Phosphorylation | - | 17.72 | 24719451 | |
| 358 | Phosphorylation | PKDPAAVTESKEGTE CCCCCCCCCCCCCCH | 29.79 | 20068231 | |
| 360 | Phosphorylation | DPAAVTESKEGTEAS CCCCCCCCCCCCHHH | 27.00 | 20068231 | |
| 360 (in isoform 2) | Phosphorylation | - | 27.00 | 28450419 | |
| 360 (in isoform 4) | Phosphorylation | - | 27.00 | 28450419 | |
| 361 (in isoform 1) | Ubiquitination | - | 54.66 | 21890473 | |
| 361 | Ubiquitination | PAAVTESKEGTEASA CCCCCCCCCCCHHHH | 54.66 | 21906983 | |
| 364 (in isoform 2) | Phosphorylation | - | 29.48 | 30266825 | |
| 364 (in isoform 4) | Phosphorylation | - | 29.48 | 30266825 | |
| 364 | Phosphorylation | VTESKEGTEASASKG CCCCCCCCHHHHHCC | 29.48 | 28857561 | |
| 366 (in isoform 2) | Phosphorylation | - | 15.38 | 30266825 | |
| 366 (in isoform 4) | Phosphorylation | - | 15.38 | 30266825 | |
| 367 | Phosphorylation | SKEGTEASASKGLEK CCCCCHHHHHCCCCC | 27.18 | 12077416 | |
| 368 (in isoform 4) | Phosphorylation | - | 23.47 | 30266825 | |
| 368 (in isoform 2) | Phosphorylation | - | 23.47 | 30266825 | |
| 369 | Phosphorylation | EGTEASASKGLEKKE CCCHHHHHCCCCCCC | 25.43 | 23312004 | |
| 370 (in isoform 1) | Ubiquitination | - | 68.20 | 21890473 | |
| 370 | Ubiquitination | GTEASASKGLEKKEK CCHHHHHCCCCCCCC | 68.20 | 2190698 | |
| 371 (in isoform 4) | Phosphorylation | - | 36.25 | 30266825 | |
| 371 (in isoform 2) | Phosphorylation | - | 36.25 | 30266825 | |
| 375 (in isoform 2) | Phosphorylation | - | 62.45 | 28450419 | |
| 375 (in isoform 4) | Phosphorylation | - | 62.45 | 28450419 | |
| 392 (in isoform 2) | Phosphorylation | - | 28796482 | ||
| 395 (in isoform 2) | Phosphorylation | - | 28796482 | ||
| 410 (in isoform 2) | Ubiquitination | - | 21890473 | ||
| 419 (in isoform 2) | Ubiquitination | - | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HM13_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HM13_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HM13_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SSRA_HUMAN | SSR1 | physical | 22939629 | |
| DERL1_HUMAN | DERL1 | physical | 25239945 | |
| RN139_HUMAN | RNF139 | physical | 25239945 | |
| XBP1_HUMAN | XBP1 | physical | 25239945 | |
| LZTS2_HUMAN | LZTS2 | physical | 25416956 | |
| AT2B1_HUMAN | ATP2B1 | physical | 26344197 | |
| AT2B3_HUMAN | ATP2B3 | physical | 26344197 | |
| AT2B4_HUMAN | ATP2B4 | physical | 26344197 | |
| STOM_HUMAN | STOM | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-10 AND ASN-20, AND MASSSPECTROMETRY. | |